Geron to Announce Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019
February 28 2019 - 4:30PM
Geron Corporation (Nasdaq: GERN) today announced that it will
release its fourth quarter and full year 2018 financial results
after the market closes on Thursday, March 7, 2019 via press
release, which will be available on the Company’s website at
www.geron.com/investors. Geron will host a conference call to
discuss the financial results as well as recent events at 4:30 p.m.
ET the same day.
Participants may access the conference call live via telephone
by dialing domestically +1 (877) 303-9139 or internationally +1
(760) 536-5195. The passcode is 6771719. Participants are advised
to dial in at least 10 minutes prior to minimize any delay in
joining the call. A live, listen-only webcast will also be
available on the Company’s website at
www.geron.com/investors/events. If you are unable to listen to the
live call, an archived webcast will be available on the Company’s
website for 30 days.
About Geron
Geron is a late-stage clinical biopharmaceutical company focused
on the development and potential commercialization of a
first-in-class telomerase inhibitor, imetelstat, in hematologic
myeloid malignancies. For more information about Geron, visit
www.geron.com.
CONTACT:
Suzanne MessereInvestor and Media Relationsinvestor@geron.com
media@geron.com
CG Capital877-889-1972
Geron (NASDAQ:GERN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From Apr 2023 to Apr 2024